Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
NextGen Ventures is a venture capital firm based in Ede, Netherlands, focused on supporting early-stage startups in the healthcare sector. The firm has a portfolio of 16 companies and primarily invests in the Netherlands, Germany, and Belgium. Their investment strategy emphasizes addressing unmet medical needs through innovative healthcare solutions.
NextGen Ventures specializes in seed and early-stage investments in digital health and medtech companies. They typically invest in startups developing hardware and software solutions that enhance healthcare efficiency and effectiveness. Their investment approach aligns with the Quadruple Aim Framework, targeting positive healthcare outcomes.
Notable companies in NextGen Ventures' portfolio include AMT-Medical, which focuses on minimally invasive heart bypass surgeries; Attendi, known for its voice-activated reporting software for healthcare professionals; and Sirius Medical. Other investments include Bloomlife, Elanza, and Flux Robotics.
Email your pitch deck to info@nextgenventures.nl for consideration.
As of October 2023: NextGen Ventures launched 'Nextgen Ventures 3' to support emerging medtech and healthtech teams. They highlighted a significant funding round for the medical startup ShanX, which raised €24 million.
NextGen Ventures often leads investment rounds, particularly in seed and early-stage funding for healthcare startups.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth and alignment with their investment thesis.
NextGen Ventures has not publicly disclosed the size of their current fund, but they actively manage a portfolio of 16 companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.